中文名称: ARQ-092
英文名称: ARQ-092
CAS No: 1313881-70-7
分子式: C27H24N6
分子量: 432.53
A10984 ARQ-092 ≥98% (psaitong)
包装规格:
5mg 10mg 25mg 100mg in glass bottle
溶解性:
溶于DMSO
产品描述:

基本信息

产品编号:

A10984

产品名称:

ARQ-092

CAS:

1313881-70-7

 

储存条件

粉末

-20℃

四年

 

 

分子式:

C27H24N6

溶于液体

-80℃

6个月

分子量:

432.53

-20℃

1个月

化学名: 

Miransertib;3-(3-(4-(1-aminocyclobutyl)phenyl)-5-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amine

Solubility (25°C):

 

体外:

 

DMSO

8mg/mL (18.49mM)

Ethanol

Insoluble

Water

Insoluble

体内(现配现用):

请根据您的实验动物和给药⽅式选择适当的溶解⽅案。以下溶解⽅案都请先按照In Vitro⽅式配制澄清的储备液,再依次添加助溶剂:为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的⼯作液,建议您现⽤现配,当天使⽤;以下溶剂前显⽰的百分⽐是指该溶剂在您配制终溶液中的体积占⽐;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的⽅式助溶

1.请依序添加每种溶剂:10% DMSO40% PEG3005% Tween-8045% saline

Solubility:≥1.25mg/mL(2.89mM);Clear solution

1mg/ml表示微溶或不溶。

普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。

 

制备储备液

 

浓度

 

溶液体积

质量

 

1mg

 

5mg

 

10mg

1mM

2.3120mL

11.5602mL

23.1203mL

5mM

0.4624mL

2.3120mL

4.6241mL

10mM

0.2312mL

1.1560mL

2.3120mL

 

生物活性

产品描述

一种有效的具有口服活性的选择性和变构Akt抑制剂。

靶点

Akt;Parasite

体外研究

In a large panel of cell lines derived from various tumor types,Miransertib (ARQ-092;Compound 21a) shows potent antiproliferative activity in cell lines containing PIK3CA/PIK3R1 mutations compared to those with wild-type (wt) PIK3CA/PIK3R1 or PTEN loss.Miransertib shows excellent inhibition of p-Akt (S473) and p-Akt (T308) in both AN3CA and A2780 cells.The inhibition of the downstream protein p-PRAS40 (T246) is observed with Miransertib (IC50=0.31μM).Miransertib is markedly effective against intracellular amastigotes of L.donovani or L.amazonensis-infected macrophages.Miransertib also enhances mTOR dependent autophagy in Leishmania-infected macrophages MCE has not independently confirmed the accuracy of these methods.They are for reference only.

体内研究

Miransertib (ARQ-092;Compound 21a) shows good absolute oral bioavailability in rats (5mg/kg) and monkeys (10mg/kg) with F values of 62% and 49%,respectively.The half-life is longer in rats compared to monkeys with t1/2 values of 17h in rats versus 7h in monkeys.The Cmax is 198ng/mL and 258ng/mL and the AUCinf was 5496h•ng/mL and 2960h•ng/mL in rats and monkeys,respectively.Miransertib (ARQ-092;Compound 21a) inhibits tumor growth in a human xenograft mouse model of endometrial adenocarcinoma.

 

推荐实验方法(仅供参考)

细胞实验:

 

Anti-proliferative cellular assays are conducted using the CellTiter Non-Radioactive Cell Proliferation Assay,which utilizes the production of formazan from a tetrazolium compound by live cells.AN3CA and A2780 cells are obtained from the ATCC.AN3CA cells are cultured in DMEM,and A2780 cells are cultured in RPMI.Cells are plated in 96-well plates at 2,000-10,000 cells/well,cultured for 24h,and treated with the test compound for 72h at a final DMSO concentration no greater than 0.5% v/v.PMS stock reagent (0.92mg/mL in DPBS) is diluted 20-fold in MTS stock reagent (2mg/mL in DPBS),and this MTS/PMS mixture is diluted 5-fold into each well of the 96-well plate.The plates are incubated for 3-4h,and the absorbance of formazan is measured at 490nm.The data are normalized to the untreated controls,the dose-response curves are fit to a four-parameter logistic equation,and the IC50 values are determined.All IC50 values reported are the geometric mean of at least two independent determinations.

 

动物实验:

 

Mice

SHP2Y279C/+ mice are used.Only male progeny are used for the experiments herein and all mice are maintained on outbred C57BL6/J backgrounds,backcrossed for more than 10 generations.Either vehicle or Miransertib (100mg/kg body weight) is then daily administered by oral gavage for 4 weeks.Administration began at 12 weeks of age (after established hypertrophy is indicated),and continued for 4 weeks,until the mice reach 16 weeks of age.As controls,SHP2+/+ and SHP2Y279C/+ mice are treated with vehicle alone.

保存条件:
-20℃
UN码:
HazardClass:
危害声明:
安全说明:
搜索质检报告(COA)
参考文献 & 客户发表文献

本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (g) = 浓度 (mol/L) x 体积 (L) x 分子量 (g/mol)

摩尔浓度计算公式

  • =
    *
    *
    *选择对应的单位 *空出希望得到的变量,填写另外两个变量

用本工具协助配置特定浓度的溶液,使用的计算公式为:
开始浓度 x 开始体积 = 最终浓度 x 最终体积

稀释公式

稀释公式一般简略地表示为:C1V1 = C2V2 ( 输入 输出 )

  • * = *

连续稀释计算器方程

  • 连续稀释

  • 初始浓度:
  • 稀释倍数:
  • 计算结果

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):